Last update 08 Apr 2025

SVT-15652

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
SVT-15652(Laboratorios SALVAT), SVT 15652, SVT15652
Target-
Action-
Mechanism-
Therapeutic Areas
Otorhinolaryngologic Diseases
Active Indication
Otitis Externa
Inactive Indication
Otomycosis
Originator Organization
Laboratorios Salvat SALaboratorios Salvat SA
Active Organization
Laboratorios Salvat SALaboratorios Salvat SA
Inactive Organization
Editorial Salvat SLEditorial Salvat SL
Drug Highest PhaseNDA/BLA
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with SVT-15652
NCT03686397
/ CompletedPhase 3
A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of SVT-15652 Otic Solution Compared to Placebo for the Treatment of Fungal Otitis Externa (Otomycosis).
NCT03686384
/ CompletedPhase 3
A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of SVT-15652 Otic Solution Compared to Placebo for the Treatment of Fungal Otitis Externa (Otomycosis)
100 Clinical Results associated with SVT-15652
Login to view more data
100 Translational Medicine associated with SVT-15652
Login to view more data
100 Patents (Medical) associated with SVT-15652
Login to view more data
100 Deals associated with SVT-15652
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Otitis ExternaNDA/BLA
United States
Laboratorios Salvat SALaboratorios Salvat SA
-
OtomycosisPhase 3
United States
Editorial Salvat SLEditorial Salvat SL
27 Feb 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03686384 (CTgov)
Phase 3
Otomycosis
217
(SVT-15652)
pnhuetkude = caznahfltz yjupjgrfdk (smdiatzkcb, ypnqnxcxke - idacvkgeet)
View more
-
18 Jan 2023
Placebo
(Placebo)
pnhuetkude = pzyzkwrmjz yjupjgrfdk (smdiatzkcb, fngahxvaaz - jlnzetcyaj)
View more
NCT03686397 (CTgov)
Phase 3
Otomycosis
194
(SVT-15652)
wgygvpswws = pauayaqahn npupwtxqsc (lknoatdhoi, iszvqkesmk - ubgazfffsb)
View more
-
15 Dec 2022
Placebo
(Placebo)
wgygvpswws = byjutwbqmp npupwtxqsc (lknoatdhoi, ckumsdlgzp - ijwcitefhg)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free